Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #449914 on Anavex Life Sciences Corp (AVXL)
georgejjl
01/28/24 7:44 PM
#449922 RE: BAR123 #449914
Failure is not whether or not a company hit all endpoints exactly. It is whether or not the FDA, the key opinion leaders and the patients/care givers believe that there is enough benefit to the patients to warrant approval. This is exactly what happened with Sarapta. The trial is a failure when the FDA says it is in the USA.
crescentmotor
01/28/24 8:21 PM
#449927 RE: BAR123 #449914
The trial is a failure when the FDA says it is in the USA.